Seeking Alpha

D. Mero

View D. Mero's StockTalks BY TICKER:
  • D. Mero
    Activist Trying To Unlock A Potential 65% Upside In Neptune $NEPT http://seekingalpha.com/a/19wsn
    Tue, 8:57 AM
    Reply
      • D. Mero
        With Favorable Shift In Advance Wound Care Market, Alliqua Could Grow Revenues To $35M Within 3 Years $ALQA http://seekingalpha.com/a/19kdp
        Apr 4, 8:13 AM
        Reply (8)
      • View all 8 replies
        • dindin21: Wish I would have gotten in....Took the bait on some other names yesterday. Maybe I will get a second chance.
          Wed, 2:52 PM
        • valuefinder: yaa i wish i got more @ 6.5 :-)
          Wed, 3:25 PM
          • D. Mero
            Mediwound IPO Suggests Upside For Others In Wound Care $MDWD http://seekingalpha.com/a/198x7
            Mar 26, 3:38 PM
            Reply
              • D. Mero
                3D Printing Investors Should Do As Insiders And Sell Proto Labs; Buy Alphaform Instead $AFRMF http://seekingalpha.com/a/18nhj
                Mar 12, 7:57 AM
                Reply
                  • D. Mero
                    Marketing Strategy Could Distinguish Neptune With Industry Leading Status $NEPT http://seekingalpha.com/a/189x7
                    Mar 4, 8:46 AM
                    Reply
                      • D. Mero
                        Ekso And 3D Printing Have More In Common Than Just A Partnership $EKSO http://seekingalpha.com/a/17phd
                        Feb 22, 1:13 PM
                        Reply
                          • D. Mero
                            Placenta Based Treatments Crowding Out Legacy Products In Wound Care $ALQA http://seekingalpha.com/a/17ovz
                            Feb 21, 8:34 AM
                            Reply
                              • D. Mero
                                $ONVO opportunities warant the current valuation http://seekingalpha.com/a/15xv1
                                Jan 21, 12:52 PM
                                Reply (3)
                              • View all 3 replies
                                • rdunga: RBCC is a much better pick in terms of value for tissue engineering.
                                  Jan 21, 2:29 PM
                                • janeborrowman: rdunga: How do you figure? Morningstar says re RBCC: "Rainbow Coral Corp operates a retail fish store & coral farm facility." What gives??
                                  Feb 7, 11:42 AM
                                  • D. Mero
                                    $NEPT $ENZY $ACST $AMRN New article on the omega-3 market and involved players http://seekingalpha.com/a/15y9h
                                    Jan 21, 12:51 PM
                                    Reply
                                      • D. Mero
                                        Neptune Erecting A Moat In Omega-3; Shares Undervalued $NEPT http://seekingalpha.com/a/15y9h
                                        Jan 21, 11:46 AM
                                        Reply
                                          • D. Mero
                                            Can Organovo's opportunities warrant its valuation? http://seekingalpha.com/a/15xv1
                                            Jan 21, 9:50 AM
                                            Reply
                                              • D. Mero
                                                Organovo's Opportunities Validate Rising Valuation $ONVO http://seekingalpha.com/a/15xv1
                                                Jan 21, 9:13 AM
                                                Reply
                                                  • D. Mero
                                                    $INO interview with CEO Dr.Joseph Kim http://seekingalpha.com/a/14xjj
                                                    12/20/13
                                                    Reply
                                                      • D. Mero
                                                        $NUAN: How the transition to subscription revenue has been misunderstood by the market http://seekingalpha.com/a/14sn5
                                                        12/17/13
                                                        Reply
                                                          • D. Mero
                                                            $HOLX: Oversight changes are a result of Icahn effect. Won't happen overnight, but shareholders will be rewarded. Next up: $NUAN
                                                            12/14/13
                                                            Reply
                                                              • D. Mero
                                                                $NUAN: Leader in a growing market and Icahn 20% stake make company an attractive turnaround candidate
                                                                12/13/13
                                                                Reply (1)
                                                                • 1980XLS: Dragon!
                                                                  12/13/13